AMAL
Amalgamated Financial Corp.
AMAL offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
GS
The Goldman Sachs Group, Inc.
GS has the edge over AMAL overall, supported by stronger valuation and stronger fundamentals.
AMAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AMAL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AMAL.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
AMAL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $31.28 | -38% |
| Fair | 9.8x | $39.80 | -21% |
| Forward | 11x | $50.08 | — |
| Expensive | 12x | $47.33 | -5.5% |
| Current | 12x | $50.08 | — |
Historical ranges are pointers, not guarantees.
AMAL has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
AMAL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
AMAL has the edge over GS on the outlook, with more favorable valuation expectations.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
AMAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.46 | +9.5% |
| Q3 2026 | $4.07 | +23% |
| Q2 2026 | $3.75 | +13% |
| Q1 2026 | $3.44 | +2.4% |
| Q4 2025 | $3.41 | -0.9% |
| Q3 2025 | $3.31 | -2.6% |
| Q2 2025 | $3.33 | +3.1% |
| Q1 2025 | $3.36 | +9.8% |
| Q4 2024 | $3.44 | +20% |
AMAL earned $4.07 per share over the past year, up 23% from the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over AMAL on earnings, with more consistent year-over-year improvement.
AMAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $101.7M | +19% |
| Q2 2026 | $98.4M | +22% |
| Q1 2026 | $93.4M | +21% |
| Q4 2025 | $85.2M | +9.4% |
| Q3 2025 | $85.6M | +5.6% |
| Q2 2025 | $80.9M | +3.2% |
| Q1 2025 | $77M | -1.6% |
| Q4 2024 | $77.9M | +1.5% |
AMAL's revenue has grown year over year for six quarters in a row: $102M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 48% | +5.5 points |
| Q2 2026 | 47% | +3.6 points |
| Q1 2026 | 36% | -8.7 points |
| Q4 2025 | 39% | -3.4 points |
| Q3 2025 | 43% | -4.3 points |
| Q2 2025 | 44% | -1.8 points |
| Q1 2025 | 45% | -4.1 points |
| Q4 2024 | 42% | -3.5 points |
AMAL has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over AMAL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
AMAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33M | -14% |
| Q2 2026 | $19.6M | -24% |
| Q1 2026 | $50.7M | +56% |
| Q4 2025 | $38M | +34% |
| Q3 2025 | $38.3M | +8.8% |
| Q2 2025 | $25.6M | -7.7% |
| Q1 2025 | $32.5M | +4.5% |
| Q4 2024 | $28.3M | +88% |
AMAL has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
AMAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +52K shares |
| 1 year | -0.6% | -170K shares |
| 3 years | -1.1% | -349K shares |
| 5 years | -3.9% | -1.2M shares |
AMAL has 30M diluted shares, down 0.6% from a year ago, with $18M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.5M |
| Q2 2026 | — |
| Q1 2026 | $2.8M |
| Q4 2025 | $8.7M |
| Q3 2025 | $10.4M |
| Q2 2025 | $9.7M |
| Q1 2025 | $3.5M |
| Q4 2024 | $845,000 |
AMAL spent $18M buying back its own shares over the past year, down 26% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over AMAL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
AMAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 1.7x | Healthy |
AMAL has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AMAL.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over AMAL on leverage, with a lower net debt burden relative to earnings.
AMAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.6 | Neutral |
| Stochastic | 66.4 | Neutral |
AMAL's weekly RSI is 63 (neutral) and its Stochastic is 66 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
AMAL PE vs Financial Services Sector
| Metric | AMAL | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.5% below |
| PE % | 89 | 63 | 26 pts above |
AMAL has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
AMAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.7 | 2.8% above |
| 20 week MA | $48.6 | 3.1% above |
| 50 week MA | $42.8 | 17% above |
| 100 week MA | $36.5 | 37% above |
| 200 week MA | $30.1 | 66% above |
AMAL has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
AMAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $13.6 | -30% |
| 2021 | $13.6 | $16.7 | +22% |
| 2022 | $16.7 | $23.1 | +39% |
| 2023 | $23.1 | $26.9 | +17% |
| 2024 | $26.9 | $33.7 | +25% |
| 2025 | $33.7 | $32.7 | -3% |
| 2026 YTD | $32.7 | $50.1 | +53% |
AMAL has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.